When Diversity Goals Meet Multiregional Trials.

N Engl J Med

From the Oncology Center of Excellence (G.U.M., R.P.) and the Office of the Commissioner (N.N.B., R.M.C.), Food and Drug Administration, Silver Spring, MD.

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp2409392DOI Listing

Publication Analysis

Top Keywords

diversity goals
4
goals meet
4
meet multiregional
4
multiregional trials
4
diversity
1
meet
1
multiregional
1
trials
1

Similar Publications

Background: The wellbeing of over 11 million care partners of people living with Alzheimer's disease and related dementias (ADRD) in the United States is increasingly recognized as a public health priority. Addressing care partners' needs for support and services is particularly important, as care partner burden is associated with negative health outcomes in care partners and people living with ADRD. Care partners from marginalized populations experience inequities in research participation, care burden, and access to supports and services.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Mississippi State Department of Health, Jackson, MS, USA.

Background: With Alzheimer's Disease and Related Dementias (ADRD) posing significant public health challenges globally, effective strategies that encompass policy, practice, and community engagement are essential. The Mississippi State Department of Health (MSDH) has implemented an integrated approach to ADRD, focusing on three critical themes: Coalitions and Collaborations, ADRD Strategic Plans, and Healthy Brain Initiative (HBI) Road Map Implementation. This case study provides valuable insights into a comprehensive public health approach towards ADRD.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Background: Vascular risk factors are known contributors to cognitive decline and dementia; however, their impact on cognitive change in diverse samples is understudied. In this study, we investigated the effect of the AHA Life's Simple 7 (LS7) on cognitive decline in the bi-ethnic San Antonio Longitudinal Study of Aging (SALSA) cohort.

Method: We included 403 participants (mean age 57.

View Article and Find Full Text PDF

Background: The 2021 WHO report highlights the importance of global planning for dementia. Initiatives that unite and support young leaders and stakeholders from diverse backgrounds in dementia care & research are crucial. The G8 Summit on Dementia in 2013 led to the creation of the World Dementia Council and the World Young Leaders in Dementia (WYLD) network, which connects professionals to work together on finding solutions to dementia challenges.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Biogen, Cambridge, MA, USA.

Background: Alzheimer's disease is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and impairment of daily functioning. It disproportionately affects certain racial and ethnic groups, with African Americans and Hispanics being 2 and 1.5 times more likely to develop Alzheimer's disease compared to white non-Hispanic Americans, respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!